Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT07850817
NA

Anti-Wrinkle Efficacy of a Syringic Acid-Containing Emulsion

Sponsor: BioSpectrum Inc

View on ClinicalTrials.gov

Summary

This randomized, double-blind, split-face controlled study was conducted to evaluate the anti-wrinkle efficacy and safety of a Syringic acid-containing emulsion in healthy female subjects. The test product was an emulsion containing 2% Synox, a Syringic acid-containing ingredient, while the control product was an emulsion without Synox. Participants applied the test and control products to opposite sides of the face according to random allocation for 12 weeks. Skin wrinkle-related parameters were evaluated at baseline and after 4, 8, and 12 weeks of product use using visual assessment, replica-based instrumental measurement, and subject questionnaires. Skin safety was monitored throughout the study period.

Official title: A Randomized, Double-Blind, Split-Face Controlled Study to Evaluate the Anti-Wrinkle Efficacy and Safety of a Syringic Acid-Containing Emulsion in Healthy Subjects

Key Details

Gender

All

Age Range

30 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

23

Start Date

2015-01-12

Completion Date

2015-04-17

Last Updated

2026-09-30

Healthy Volunteers

Yes

Interventions

OTHER

Synox-containing Emulsion

A cosmetic emulsion containing 2% Synox, a raw material containing 1% Syringic acid, was applied topically for 12 weeks.

OTHER

Control Emulsion

A vehicle control emulsion without Synox was applied to the contralateral side of the face for 12 weeks.

Locations (1)

Dermapro Co., Ltd.

Seoul, South Korea